PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response
Open Access
- 7 July 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (8) , 10751-10761
Abstract
Inflammatory responses are pivotal incidences in hepatic metabolic derangements. However, the underlying mechanism remains elusive. The present study aimed to evaluate the role of peroxisome proliferator‐activated receptor‐gamma, coactivator 1 alpha (PGC1α) in IL10‐mediated anti‐inflammatory response, and its role in hepatic steatosis and insulin resistance. Hepatocyte‐specific PGC1α knock‐in (LivPGC1α) mice and the control mice were fed high‐fat diet (HFD) for 8 weeks. IL‐10 neutralizing antibody was injected into the liver of PGC1α mice. A variety of biological and histological approaches were applied to assess hepatic function. We demonstrated that hepatic PGC1α expression was significantly reduced in mice fed HFD. LivPGC1α livers exhibited enhanced gene expressions involving mitochondrial function, and favored an accelerated lipid metabolism upon HFD. Meanwhile, LivPGC1α mice revealed improved hepatic steatosis and insulin resistance. Mechanistically, PGC1α bound and activated the promotor region of IL‐10, thereby attenuating inflammatory response in the liver. Administration of IL10 neutralizing antibody to LivPGC1α mice abolished PGC1α‐mediated anti‐inflammatory effects in mice. Further, IL‐10 neutralizing antibody intervention aggravated hepatic steatosis and insulin resistance in LivPGC1α mice. Taken together, our data indicated that hepatic‐specific overexpression of PGC1α exerts a beneficial role in the regulation of hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response. Pharmacological activation of PGC1α‐IL10 axis may be promising for the treatment of fatty liver diseases.Keywords
Funding Information
- National Natural Science Foundation of China (#91749203, #81525010, #81570523, #81400221, #81700511)
- National Natural Science Foundation of China (#2016YFA0100602, #2017YFA0103302, #2017YFC0908900)
- National Natural Science Foundation of China (#2017ZT07S347)
- National Natural Science Foundation of China (#2018GZR110103002)
- National Natural Science Foundation of China (#2C32003)
- National Natural Science Foundation of China (#PF14002004017)
- National Natural Science Foundation of China (#LY20H030004)
- National Natural Science Foundation of China (#2017193668)
This publication has 37 references indexed in Scilit:
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisNature Reviews Gastroenterology & Hepatology, 2013
- Temporal clustering of gene expression links the metabolic transcription factor HNF4α to the ER stress-dependent gene regulatory networkFrontiers in Genetics, 2013
- Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinaseGenes & Development, 2011
- Telomere dysfunction induces metabolic and mitochondrial compromiseNature, 2011
- The regulation of IL-10 production by immune cellsNature Reviews Immunology, 2010
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and InflammationCell Metabolism, 2009
- PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophyGenes & Development, 2007
- PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic SteatosisPLOS Biology, 2005
- Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1Cell, 1999
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998